 |
|
RADIOACTIVE ISOTOPES IN MANAGEMENT OF CARCINOMATOSIS OF SEROUS BODY CAVITIES
EDWARD M. KENT, M.D.;
CAMPBELL MOSES, M.D.;
WILLIAM B. FORD, M.D.;
EUGENE R. KUTZ, M.D.;
ROBERT S. GEORGE, M.D.
AMA Arch Intern Med. 1954;94(3):334-340.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
THE CONTINUING, accelerating struggle for mastery over malignant diseases in the human has resulted in some tendency to overlook the need for and the availability of weapons with which we may attempt to achieve palliation. By and large this field of endeavor has been all too eagerly reserved for those few persons who have grasped the responsibility which actually rests upon all of us. Admittedly, such a solution has much genuine merit, however, available personnel and facilities are so meager for the problem at hand that many victims of cancer receive little or no considerate, planned therapy aimed at the production of a maximum degree of aid and comfort.
The onset of intractable effusion in one or more of the serous cavities is a distressing complication of advancing malignant disease. The true frequency with which such a state is reached cannot be estimated with accuracy; however, Clark 1 has reported that significant
. . . [Full Text PDF of this Article]
Author Affiliations
PITTSBURGH
From the Department of Surgery and the Addision H. Gibson Laboratory of the University of Pittsburgh School of Medicine and the Department of Radiology, Allegheny General Hospital.
Footnotes
This research has been supported by grants from the American Cancer Society.
The discussion of this paper was opened by Dr. John H. Lawrence, Berkeley, Calif., and Dr. Ralph M. Knisely, Oak Ridge, Tenn.
Read before the Section on Internal Medicine, at the 103rd Annual Meeting of the American Medical Association, San Francisco, June 23, 1954.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
